Cargando…

P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells

Detalles Bibliográficos
Autores principales: van Loenen, MM, de Boer, R, van Liempt, E, Hagedoorn, RS, Meij, P, Jedema, I, Falkenburg, JHF, Heemskerk, MHM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072150/
http://dx.doi.org/10.1186/2051-1426-2-S2-P48
_version_ 1782322913147355136
author van Loenen, MM
de Boer, R
van Liempt, E
Hagedoorn, RS
Meij, P
Jedema, I
Falkenburg, JHF
Heemskerk, MHM
author_facet van Loenen, MM
de Boer, R
van Liempt, E
Hagedoorn, RS
Meij, P
Jedema, I
Falkenburg, JHF
Heemskerk, MHM
author_sort van Loenen, MM
collection PubMed
description
format Online
Article
Text
id pubmed-4072150
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40721502014-06-27 P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells van Loenen, MM de Boer, R van Liempt, E Hagedoorn, RS Meij, P Jedema, I Falkenburg, JHF Heemskerk, MHM J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072150/ http://dx.doi.org/10.1186/2051-1426-2-S2-P48 Text en Copyright © 2014 van Loenen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
van Loenen, MM
de Boer, R
van Liempt, E
Hagedoorn, RS
Meij, P
Jedema, I
Falkenburg, JHF
Heemskerk, MHM
P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
title P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
title_full P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
title_fullStr P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
title_full_unstemmed P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
title_short P74. A Good Manufacturing Practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific T-cells
title_sort p74. a good manufacturing practice procedure to generate therapeutic numbers of highly pure anti-leukaemic virus-specific t-cells
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072150/
http://dx.doi.org/10.1186/2051-1426-2-S2-P48
work_keys_str_mv AT vanloenenmm p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells
AT deboerr p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells
AT vanliempte p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells
AT hagedoornrs p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells
AT meijp p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells
AT jedemai p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells
AT falkenburgjhf p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells
AT heemskerkmhm p74agoodmanufacturingpracticeproceduretogeneratetherapeuticnumbersofhighlypureantileukaemicvirusspecifictcells